Domov › Schizofrénia › Illinois › Chicago
Klinické štúdie Schizofrénia v meste Chicago, IL
21 štúdií pre Schizofrénia hľadá účastníkov v zariadeniach v meste Chicago a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Cognitive Neurocomputational Task Reliability & Clinical Applications Consortium (CNTRACS): Study 1
Prebieha náborVítaní zdravých dobrovoľníkov
- The University of Chicago, Chicago
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
Prebieha náborFáza 1
- Uptown Research Institute, Chicago
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
Prebieha náborFáza 3
- Local Institution - 0067, Chicago
- Pillar Clinical Research -Chicago, Chicago
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizophrenia
Prebieha náborFáza 3
- Neurocrine Clinical Site, Chicago
A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
Prebieha náborFáza 3
- Local Institution - 0175, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study of Brenipatide in Adult Participants With Schizophrenia
Prebieha náborFáza 2
- Re:Cognition Health - Chicago, Chicago
52-week Open Label Safety-Tolerability Study
Prebieha náborFáza 3
- Pillar Clinical Research, Chicago
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Schizophrenia in Adolescents (EMERGENT TEEN)
Prebieha náborFáza 3
- Local Institution - 0122, Chicago
- EmVenio Research Center - Prime Healthcare, Chicago
A Study to Evaluate the Safety, Tolerability, and PK of an Injectable Form of KarXT
Prebieha náborFáza 1
- Uptown Research Institute, Chicago
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
Prebieha náborFáza 2
- Clinical Site, Chicago
Study to Evaluate Weight Gain as Assessed by Change in BMI Z-score in Pediatric Subjects With Schizophrenia or Bipolar I Disorder
Prebieha náborFáza 3
- Alkermes Investigator Site, Chicago
Study to Assess the Safety, Tolerability, and Treatment Response of GXV813 in Hospitalized Adults With Schizophrenia
Prebieha náborFáza 2
- Uptown Research Institute LLC, Chicago
- Pillar Clinical Research LLC, Chicago
Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia
Prebieha náborFáza 3
- Pillar Clinical Research, Chicago
A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia
Prebieha náborFáza 2
- Uptown Research Institute, Chicago
A Study to Evaluate the Effect of KarXT on Urological Safety
Prebieha náborFáza 4
- Uptown Research Institute, Chicago
- Pillar Clinical Research -Chicago, Chicago
CLOZAPINE Response in Biotype-1
Prebieha náborFáza 4
- University of Chicago, Chicago
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
Prebieha náborObservačná štúdia
- University of Chicago Medical Center, Chicago
NBI-1117568-SCZ3029: Evaluation of NBI-1117568 in Inpatient Adults With Schizophrenia
Prebieha náborFáza 3
- Neurocrine Clinical Site, Chicago
Randomized Withdrawal Study in Patients With Schizophrenia
Prebieha náborFáza 3
- Vanda Investigational Site, Chicago
Study of ALTO-101 in Patients With Schizophrenia
Prebieha náborFáza 2
- Site 5056, Chicago
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Prebieha náborFáza 3Vítaní zdravých dobrovoľníkov
- Reviva site, Chicago
Štúdie Schizofrénia v iných mestách
- Atlanta, GA22 štúdií
- Little Rock, AR19 štúdií
- Hollywood, FL15 štúdií
- Boston, MA14 štúdií
- Houston, TX13 štúdií
- San Diego, CA13 štúdií
- Hialeah, FL13 štúdií
- New York City, NY13 štúdií
- Austin, TX13 štúdií
- Garden Grove, CA12 štúdií
- Germantown, MD11 štúdií
- Miami, FL10 štúdií
Iné štúdie v Chicago
- Nemalobunkový karcinóm pľúc61 štúdií
- Rakovina prsníka58 štúdií
- Rakovina (všetky typy)51 štúdií
- Metastatická rakovina45 štúdií
- Rakovina prostaty45 štúdií
- Obézita41 štúdií
- Rakovina pľúc41 štúdií
- Rakovina vaječníkov36 štúdií
- Cievna mozgová príhoda34 štúdií
- Kolorektálny karcinóm33 štúdií
- Srdcové zlyhanie31 štúdií
- Nadváha28 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.